Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

[Value of thallium-dipyridamole myocardial scintigraphy in coronary patients in non cardiac surgery].

Puybasset L, Gosgnach M, Baron JF, Coriat P, Viars P.

Ann Fr Anesth Reanim. 1993;12(4):409-20. Review. French.

PMID:
8273929
2.
4.

Selection of patients for cardiac evaluation before peripheral vascular operations.

Schueppert MT, Kresowik TF, Corry DC, Jacobovicz C, Mohan CR, Slaymaker E, Hoballah JJ, Sharp WJ, Grover-McKay M, Corson JD.

J Vasc Surg. 1996 May;23(5):802-8; discussion 808-9.

5.

The predictive value of dipyridamole-thallium scintigraphy for cardiac risk assessment before major vascular surgery.

Klonaris CN, Bastounis EA, Xiromeritis NC, Balas PE.

Int Angiol. 1998 Sep;17(3):171-8.

PMID:
9821031
6.

Preoperative dipyridamole-thallium scanning, selective coronary revascularization and long-term survival in patients with critical lower limb ischemia.

Wolf YG, Landersberg G, Mosseri M, Schechter D, Anner H, Weissman C, Berlatzky Y.

J Cardiovasc Surg (Torino). 2001 Feb;42(1):89-95.

PMID:
11292913
7.

Usefulness of dipyridamole-thallium scanning for preoperative evaluation of cardiac risk for nonvascular surgery.

Coley CM, Field TS, Abraham SA, Boucher CA, Eagle KA.

Am J Cardiol. 1992 May 15;69(16):1280-5.

PMID:
1585860
8.
9.
10.

Dipyridamole thallium imaging: use in preoperative cardiac risk assessment in vascular surgical patients.

Costello JM Jr, Butcher RJ, Nassef LA, Youkey J, Menapace FJ.

Coron Artery Dis. 1993 Aug;4(8):721-6.

PMID:
8261244
11.

Is coronary angiography necessary for vascular surgery patients who have positive results of dipyridamole thallium scans?

Massie MT, Rohrer MJ, Leppo JA, Cutler BS.

J Vasc Surg. 1997 Jun;25(6):975-82; discussion 982-3.

12.

Dipyridamole thallium-201 scintigraphy as a preoperative screening test. A reexamination of its predictive potential. Study of Perioperative Ischemia Research Group.

Mangano DT, London MJ, Tubau JF, Browner WS, Hollenberg M, Krupski W, Layug EL, Massie B.

Circulation. 1991 Aug;84(2):493-502.

PMID:
1860194
13.

Prognostic value of dipyridamole thallium-201 screening to minimize perioperative cardiac complications in diabetics undergoing kidney or kidney-pancreas transplantation.

Mistry BM, Bastani B, Solomon H, Hoff J, Aridge DL, Lindsey LM, Schmid S, Chaitman BR, Garvin PJ.

Clin Transplant. 1998 Apr;12(2):130-5.

PMID:
9575401
15.

Sex differences in perioperative and long-term cardiac event-free survival in vascular surgery patients. An analysis of clinical and scintigraphic variables.

Hendel RC, Chen MH, L'Italien GJ, Newell JB, Paul SD, Eagle KA, Leppo JA.

Circulation. 1995 Feb 15;91(4):1044-51.

18.

Determination of cardiac risk by dipyridamole-thallium imaging before peripheral vascular surgery.

Boucher CA, Brewster DC, Darling RC, Okada RD, Strauss HW, Pohost GM.

N Engl J Med. 1985 Feb 14;312(7):389-94.

PMID:
3871502
19.

Usefulness of the severity and extent of reversible perfusion defects during thallium-dipyridamole imaging for cardiac risk assessment before noncardiac surgery.

Lette J, Waters D, Lapointe J, Gagnon A, Picard M, Cerino M, Kerouac M.

Am J Cardiol. 1989 Aug 1;64(5):276-81.

PMID:
2756871
20.

Prognostic value of dipyridamole thallium-201 imaging in elderly patients.

Shaw L, Chaitman BR, Hilton TC, Stocke K, Younis LT, Caralis DG, Kong BA, Miller DD.

J Am Coll Cardiol. 1992 Jun;19(7):1390-8.

Items per page

Supplemental Content

Support Center